Excelsior Biopharma Inc. (6496.TWO)

TWD 30.0

(0.0%)

Net Debt Summary of Excelsior Biopharma Inc.

  • Excelsior Biopharma Inc.'s latest annual net debt in 2023 was -212.51 Million TWD , up 59.09% from previous year.
  • Excelsior Biopharma Inc.'s latest quarterly net debt in 2024 Q2 was 8.13 Million TWD , up 121.94% from previous quarter.
  • Excelsior Biopharma Inc. reported annual net debt of -519.44 Million TWD in 2022, up 26.38% from previous year.
  • Excelsior Biopharma Inc. reported annual net debt of -705.57 Million TWD in 2021, up 5.33% from previous year.
  • Excelsior Biopharma Inc. reported quarterly net debt of 8.13 Million TWD for 2024 Q2, up 121.94% from previous quarter.
  • Excelsior Biopharma Inc. reported quarterly net debt of -569.54 Million TWD for 2023 Q3, down -41.48% from previous quarter.

Annual Net Debt Chart of Excelsior Biopharma Inc. (2023 - 2019)

Historical Annual Net Debt of Excelsior Biopharma Inc. (2023 - 2019)

Year Net Debt Net Debt Growth
2023 -212.51 Million TWD 59.09%
2022 -519.44 Million TWD 26.38%
2021 -705.57 Million TWD 5.33%
2020 -745.27 Million TWD 0.0%
2019 - TWD 0.0%

Peer Net Debt Comparison of Excelsior Biopharma Inc.

Name Net Debt Net Debt Difference
Allied Biotech Corporation 178.11 Million TWD 219.314%
GeneFerm Biotechnology Co., Ltd. 31.92 Million TWD 765.642%
Easywell Biomedicals, Inc. 123.43 Million TWD 272.163%
TTY Biopharm Company Limited -705.97 Million TWD 69.898%
Synmosa Biopharma Corporation 1.52 Billion TWD 113.969%
Orient EuroPharma Co., Ltd. 3.1 Billion TWD 106.841%
Center Laboratories, Inc. 3.91 Billion TWD 105.423%
Tien Liang BioTech Co., Ltd. -57.55 Million TWD -269.228%
Orient Pharma Co., Ltd. 633.6 Million TWD 133.54%
InnoPharmax Inc. -17.85 Million TWD -1090.016%
Johnson Chemical Pharmaceutical Works Co., Ltd. -926.77 Million TWD 77.07%
DV Biomed Co., Ltd. 160.7 Million TWD 232.242%
Foresee Pharmaceuticals Co., Ltd. -781.42 Million TWD 72.804%
Handa Pharmaceuticals, Inc. -653.8 Million TWD 67.496%
UniPharma Co., Ltd. -68.36 Million TWD -210.841%
Anxo Pharmaceutical Co., Ltd. 492.4 Million TWD 143.158%
Alar Pharmaceuticals Inc. -738.05 Million TWD 71.206%
Winston Medical Supply Co., Ltd. -191.81 Million TWD -10.793%
Mercury Biopharmaceutical Corporation -1.94 Million TWD -10826.118%
Bioray Biotech Co., Ltd -27.23 Million TWD -680.38%
TSH Biopharm Corporation Limited -568.74 Million TWD 62.635%